GenSight Biologics
Latest round
- Series B
Last raised
- Oct 2015
Total raised
- $62M
Investors
- 10
About GenSight Biologics
A.GenSight Biologics specializes in gene therapy for ophthalmic conditions, founded in 2012 in Paris, France.A. Their primary product offerings include GS010, a gene therapy based on lenadogene nolparvovec specifically designed for Leber Hereditary Optic Neuropathy (LHON), and GS030, which utilizes optogenetics technology to restore vision in patients with retinal degenerative diseases. These therapies are intended to provide innovative treatment options for individuals suffering from vision loss caused by genetic conditions.GenSight Biologics generates revenue through the commercialization of its gene therapy products, particularly GS010 and GS030. The company is focused on launching new gene therapies and expanding into new markets, particularly in Europe and North America, to address unmet medical needs.
Who invested in GenSight Biologics
10 investors across 3 rounds
See all investors in GenSight Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GenSight Biologics
Who invested in GenSight Biologics?
GenSight Biologics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenSight Biologics raised?
GenSight Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GenSight Biologics last raise money?
GenSight Biologics's most recent round on record is a Series B, in Oct 2015.
What does GenSight Biologics do?
GenSight Biologics is a pharmaceuticals company.
Where is GenSight Biologics headquartered?
GenSight Biologics is headquartered in Paris, France.
Which VCs invest in companies like GenSight Biologics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at GenSight Biologics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like GenSight Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.